UCP1 and obesity disorder: Recently, the Kajimura group demonstrated that the β3-adrenergic receptor (β3-AR) agonist treatment of UCP1+ adipocyte-specific autophagy-null mice enhanced beige adipocyte maintenance and attenuated diet-induced obesity [61].